Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
Femasys Inc. announced CE Mark approval for its FemHSG™ Catheter, expanding its fertility care portfolio in Europe. The catheter supports efficient in-office fertility diagnostics when used with the FemVue device. This approval strengthens Femasys' position in the women’s health sector by offering innovative, cost-effective fertility solutions, com…